Observational Study: Safety and Effectiveness of Obinutuzumab in Chronic Lymphocytic Leukemia in Argentina
- Cancer
- Leukemia
- Chronic Lymphocytic Leukemia
Completed
- Argentina
NCT03059251 ML30187
Trial Summary
This observational study aims to study the effectiveness and safety of Obinutuzumab in common clinical practice settings in Argentina. The study population comprises all patients with chronic lymphocytic leukemia (CLL) that have received the indication for treatment with Obinutuzumab as per routine clinical practice.
An Observational Study of the Safety and Effectiveness of Obinutuzumab in Patients With Chronic Lymphocytic Leukemia Treated in Argentina
Eligibility Criteria
- Have received at least one dose of Obinutuzumab as per local label and clinical practice.
- Included in clinical trial
For the latest version of this information please go to www.forpatients.roche.com